3rd Quarter - Amendment

PFIZER INC. for PFIZER INC.

Firm
Client
Income
—
Expenses
$1,670,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report Oct 20, 2016 $1,620,000 Replaced
3rd Quarter - Amendment (this page) Aug 3, 2017 $1,670,000 Yes

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Trans Pacific Partnership Negotiations Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP) Canada IP/Trade Issues South Africa IP Issues China IP Issues Indonesia IP Issues Thailand IP Issues Korea Pricing Issues Saudia Arabia Pricing Issues United Nations Health Panel Privacy Shield G7/G20 APEC OECD

LobbyistCovered position, as disclosed
KEN W COLE —
DOUGLAS REID GOUDIE —
JOHN PAUL HALLIWELL —
MARY BRIDGET WALSH —

Contacted: State, Dept of (DOS); Executive Office of the President (EOP); Natl Economic Council (NEC); Natl Security Council (NSC); Treasury, Dept of; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); Commerce, Dept of (DOC)

Medicare/Medicaid MMM

Medicare Rebates/Medicare Part D Non-Interference Medicare Part B Reimbursement Medicare Part B CMMI Demo

LobbyistCovered position, as disclosed
PAULA BURG —
KEN W COLE —
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —
MARY BRIDGET WALSH —
JENNIFER SWENSON WALTON —

Contacted: Commerce, Dept of (DOC); Natl Economic Council (NEC); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); SENATE; State, Dept of (DOS); Treasury, Dept of; U.S. Trade Representative (USTR); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); Natl Security Council (NSC); HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Deferral Comprehensive Tax Reform Territorial Systems Patent Innovation Box Inversions Section 385 Proposed Regulations

LobbyistCovered position, as disclosed
PAULA BURG —
KEN W COLE —
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —
CAROLINE MOODY SCHELLHAS —
MARY BRIDGET WALSH —

Contacted: Natl Economic Council (NEC); Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Natl Security Council (NSC); Commerce, Dept of (DOC); Treasury, Dept of; Food & Drug Administration (FDA); Patent & Trademark Office (PTO); U.S. Trade Representative (USTR); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); SENATE

Budget/Appropriations BUD

Omnibus Appropriations Bill 2017 FDA & Labor/HHS Appropriation Bills

LobbyistCovered position, as disclosed
PAULA BURG —
KEN W COLE —
JOHN PAUL HALLIWELL —
MARY BRIDGET WALSH —
JENNIFER SWENSON WALTON —

Contacted: Natl Security Council (NSC); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Natl Economic Council (NEC); Patent & Trademark Office (PTO); Executive Office of the President (EOP); Treasury, Dept of; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Commerce, Dept of (DOC); State, Dept of (DOS); Food & Drug Administration (FDA); SENATE

Copyright/Patent/Trademark CPT

Patent Troll Legislation Defend Trade Secrets Act

LobbyistCovered position, as disclosed
PAULA BURG —
MARY BRIDGET WALSH —

Contacted: Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); SENATE; Natl Economic Council (NEC); Patent & Trademark Office (PTO); U.S. Trade Representative (USTR); Natl Security Council (NSC); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Treasury, Dept of; Health & Human Services, Dept of (HHS); State, Dept of (DOS)

Health Issues HCR

21st Century Cures Initiative Senate Innovation Project Drug Pricing Biosimilars Reimbursement Policy

LobbyistCovered position, as disclosed
PAULA BURG —
KEN W COLE —
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —
MARY BRIDGET WALSH —
JENNIFER SWENSON WALTON —

Contacted: Treasury, Dept of; Natl Security Council (NSC); Food & Drug Administration (FDA); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Executive Office of the President (EOP); Natl Economic Council (NEC); Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); SENATE; State, Dept of (DOS); HOUSE OF REPRESENTATIVES

Alcohol and Drug Abuse ALC

Prescription Drug Abuse

LobbyistCovered position, as disclosed
PAULA BURG —
KEN W COLE —
JOHN PAUL HALLIWELL —
ANGELA WALKER RIEMER —
MARY BRIDGET WALSH —

Contacted: HOUSE OF REPRESENTATIVES; Natl Security Council (NSC); Centers For Medicare and Medicaid Services (CMS); Natl Economic Council (NEC); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); Patent & Trademark Office (PTO); State, Dept of (DOS); Commerce, Dept of (DOC); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); SENATE; Treasury, Dept of

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.